Home/Filings/4/0000899243-21-005679
4//SEC Filing

Sundy John 4

Accession 0000899243-21-005679

CIK 0001807901other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 4:40 PM ET

Size

5.7 KB

Accession

0000899243-21-005679

Insider Transaction Report

Form 4
Period: 2021-02-08
Sundy John
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-08+73,78973,789 total
    Exercise: $17.75Exp: 2031-02-07Common Stock (73,789 underlying)
Footnotes (1)
  • [F1]This option award was granted on February 8, 2021. 1/4 of the shares underlying the award shall vest on February 8, 2022, with the remainder of the shares vesting in equal monthly installments following February 8, 2022 through February 8, 2025, subject to the reporting person's continued service on each applicable vesting date.

Issuer

Pandion Therapeutics, Inc.

CIK 0001807901

Entity typeother

Related Parties

1
  • filerCIK 0001817410

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:40 PM ET
Size
5.7 KB